Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
AI screening doubles attendance at diabetic retinopathy follow-up appointments in Tanzania study
00

AI screening doubles attendance at diabetic retinopathy follow-up appointments in Tanzania study

Oct 13, 2026

A trial across 24 hospitals in Tanzania conducted by the London School of Hygiene & Tropical Medicine found that AI-supported diabetic retinopathy screening almost doubled specialist follow-up attendance. Of patients needing referral, 35.9% in the AI group attended specialist care within eight weeks compared to 18.2% in standard screening. The Tanzanian Ministry of Health has committed to integrating AI diagnostics across multiple regions.

Trial results on specialist follow-up

  • ▪In a Tanzanian hospital trial, 35.9% of patients with referral-level diabetic retinopathy receiving AI-supported screening attended specialist clinics within eight weeks, compared to 18.2% receiving standard screening.
  • ▪Patients screened with AI technology in the Tanzanian trial attended specialist follow-up care in an average of 10.9 days, compared to 36.9 days for standard screening.

Comparison of AI and standard screening workflows

  • ▪Standard diabetic retinopathy screening in the Tanzanian trial required offsite image assessment by hospital staff, delaying patient results and telephone counseling by several weeks.
  • ▪Patients receiving AI-supported diabetic retinopathy screening in the Tanzanian trial obtained immediate point-of-care results and face-to-face counseling from health care workers.

Future implementation and policy response

  • ▪Researchers emphasized that expanded AI diabetic retinopathy screening in Tanzania must be paired with improved access to specialist clinics and treatments to prevent vision loss.
  • ▪The Tanzanian Ministry of Health committed to integrating AI diagnostics into diabetic eye screening programs across multiple regions of Tanzania following the trial.

Study methodology and publication

  • ▪The Tanzanian diabetic retinopathy trial results were published in The Lancet Global Health by lead author Dr. Charles R. Cleland and research colleagues.
  • ▪A study by the London School of Hygiene & Tropical Medicine evaluated 2,378 people across 24 hospitals in Tanzania to compare AI-supported diabetic retinopathy screening against standard pathways.

Debatable claims

  • ▪Tanzania should prioritize expanding specialist treatment capacity over AI screening rollout
  • ▪Immediate face-to-face counseling is the main driver of improved patient follow-up in AI screening programs

1 source

Medicalxpress
AI screening helps more people with diabetes access sight-saving eye care
View source article

Featured stories

View more in Global health security

OpenAI's annualized revenue reported at $50 billion, $20 billion below previous estimates

Oct 8, 2026 · 5 sources

Story comments

Loading comments…

Related entities

Tanzania

Topics

Global health securityPreventive medicineAI

Featured stories

View more in Global health security

OpenAI's annualized revenue reported at $50 billion, $20 billion below previous estimates

Oct 8, 2026 · 5 sources